NCT07662629 Addtional Effect of Hyperbaric Oxygen to Programmed Physical Activity on Musckoloskeletal Pain in Breast Cancer Elderly
| NCT ID | NCT07662629 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-05-07 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-05-07 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
patienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains. Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not investigated
Eligibility Criteria
Inclusion Criteria: * braest cancer survivors * patients receiving aramatase inhibitor drugs * patients with musckolskeletal pains Exclusion Criteria: * cardiac patients * respiratory patients * renal patients
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07662629 clinical trial?
This trial is open to female participants only, aged 65 Years or older, up to 75 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07662629 currently recruiting?
Yes, NCT07662629 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07662629 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT07662629 clinical trial?
NCT07662629 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.